Tecan Group AG (0QLN.L)

CHF 205.8

(-0.68%)

Net Income Summary of Tecan Group AG

  • Tecan Group AG's latest annual net income in 2023 was 132.07 Million CHF , up 9.04% from previous year.
  • Tecan Group AG's latest quarterly net income in 2024 Q2 was 22.46 Million CHF , down 0.0% from previous quarter.
  • Tecan Group AG reported an annual net income of 121.12 Million CHF in 2022, down -0.44% from previous year.
  • Tecan Group AG reported an annual net income of 121.65 Million CHF in 2021, up 17.34% from previous year.
  • Tecan Group AG reported a quarterly net income of 53.19 Million CHF for 2023 Q2, down 0.0% from previous quarter.
  • Tecan Group AG reported a quarterly net income of 132.07 Million CHF for 2023 FY, up 9.04% from previous quarter.

Annual Net Income Chart of Tecan Group AG (2023 - 2002)

Historical Annual Net Income of Tecan Group AG (2023 - 2002)

Year Net Income Net Income Growth
2023 132.07 Million CHF 9.04%
2022 121.12 Million CHF -0.44%
2021 121.65 Million CHF 17.34%
2020 103.68 Million CHF 41.71%
2019 73.16 Million CHF 3.5%
2018 70.69 Million CHF 6.23%
2017 66.54 Million CHF 22.01%
2016 54.54 Million CHF -4.56%
2015 57.14 Million CHF 42.1%
2014 40.21 Million CHF -11.94%
2013 45.67 Million CHF 8.34%
2012 42.15 Million CHF -11.36%
2011 47.55 Million CHF 193.5%
2010 16.2 Million CHF -67.16%
2009 49.34 Million CHF 92.56%
2008 25.62 Million CHF -51.08%
2007 52.37 Million CHF 28.89%
2006 40.63 Million CHF 191.24%
2005 13.95 Million CHF 9.67%
2004 12.72 Million CHF -9.65%
2003 14.08 Million CHF -57.29%
2002 32.97 Million CHF 0.0%

Peer Net Income Comparison of Tecan Group AG

Name Net Income Net Income Difference
Relief Therapeutics Holding AG -98.18 Million CHF 234.522%
Santhera Pharmaceuticals Holding AG 54.78 Million CHF -141.092%
Basilea Pharmaceutica AG 10.45 Million CHF -1163.755%
Bachem Holding AG 111.85 Million CHF -18.073%
Siegfried Holding AG 112.77 Million CHF -17.115%
Molecular Partners AG -61.98 Million CHF 313.079%